Pharmaceutical Supply Chain Reinvention (PowerPoint PPTX Slide Deck)

SUPPLY CHAIN ANALYSIS PPT DESCRIPTION

This product (Pharmaceutical Supply Chain Reinvention) is a 24-slide PPT PowerPoint presentation slide deck (PPTX), which you can download immediately upon purchase.

Intense disruption has caused forward-thinking Pharmaceutical companies to review their Supply Chain and Manufacturing operations. The phenomenon is characterized by technological innovation, transpiring customer demand patterns, and more agile and creative competitors.

Most of the Pharma companies, however, are continuing with the decade old processes and routines. They have transactional relationships with suppliers, insignificant interaction, lack of concerted efforts to progress ahead, and no vision to reap productivity rewards. The reasons for continuing with these traditional practices include tax regimes, regulatory hurdles, and stable revenues from customers dependent on existing industry offerings.

In order to survive disruption, leading Pharma companies are embracing agile principles, reducing costs, revolutionizing procurement and distribution functions, and striving to achieve operational effectiveness. Above all, they view their Supply Chain not as a cost center, but as a source of competitive edge.

Building Supply Chain Operational Excellence and Cost Reduction competencies are crucial for Pharma businesses to survive. This presentation talks about the 5 strategic steps (phases) necessary for developing these critical competencies.

The slide deck also includes some slide templates for you to use in your own business presentations.

To tackle disruption, Pharmaceutical businesses must abandon traditional practices and mindsets that were earlier considered a formula for lasting success. The presentation outlines how Pharma companies can embrace a more flexible approach to managing complexities, including the adoption of lean inventories and customized supply chains for each product and market. This shift is essential for maintaining competitiveness in an environment where high-margin drugs are increasingly threatened by generics.

The PPT also delves into the critical role of regulatory compliance and the impact of stricter regulations on the industry. It emphasizes the importance of aligning manufacturing strategies with local regulations to ensure seamless operations. The comprehensive guide provides actionable insights and strategic steps to help Pharma companies navigate these challenges and transform their supply chains into a source of competitive advantage.

Source: Best Practices in Supply Chain Management, Pharma Industry PowerPoint Slides: Pharmaceutical Supply Chain Reinvention PowerPoint (PPTX) Presentation Slide Deck, LearnPPT Consulting

SUPPLY CHAIN ANALYSIS PPT SLIDES

Tailored Supply Chain Strategies for Pharmaceuticals

This PPT slide outlines a strategic framework for reinventing the pharmaceutical supply chain, emphasizing the need for a tailored approach rather than a one-size-fits-all model. It begins by critiquing the traditional strategy employed by large pharmaceutical multinational corporations (MNCs), which typically involves maintaining high inventory and service levels across all products. This method is deemed ineffective for low-margin products and fluctuating demand patterns.

The slide suggests that the optimal strategy involves creating distinct supply chains that are customized based on individual products, markets, and customer needs. For high-volume products that face significant demand and competition from generics, cost considerations become crucial. The recommended approach includes manufacturing these products in countries with lower labor costs while also maintaining lean inventory levels that reflect historical trends and future demand forecasts.

For high-margin, patent-protected drugs, the slide advocates for a more complex supply chain. This includes establishing manufacturing facilities in developed economies close to market demands and ensuring there is a backup production source to maintain product continuity during emergencies.

Overall, the content stresses the importance of flexibility and responsiveness in supply chain management, particularly in the pharmaceutical sector. The insights provided can guide executives in making informed decisions about supply chain strategies that align with specific product characteristics and market dynamics.

Strategic Outsourcing for Demand Management in Pharma

This PPT slide outlines a strategic approach for pharmaceutical companies to manage demand fluctuations through outsourcing manufacturing to third-party suppliers. It emphasizes the importance of establishing partnerships with these suppliers as part of the fourth phase of the Pharmaceutical Supply Chain Reinvention framework.

The details section highlights the necessity of a Make-versus-Buy Strategy, which helps organizations decide whether to utilize third-party manufacturers or maintain in-house production capabilities. This decision is crucial during periods of low demand, where outsourcing can mitigate risks associated with underutilized manufacturing facilities and fixed costs.

It points out that outsourcing is particularly viable when product volume is low and the technology involved is not advanced. Conversely, in-house manufacturing is recommended for top-selling products that require high-tech processes and where preserving intellectual property is essential. This dual approach allows companies to balance operational efficiency with innovation needs.

The overview succinctly captures the essence of the strategy, indicating that shifting manufacturing to third parties can effectively address demand variability. The slide suggests that careful consideration of market conditions and product portfolios is vital to making informed decisions about manufacturing strategies.

Overall, this content serves as a guide for executives to navigate the complexities of supply chain management in the pharmaceutical sector, providing insights into optimizing production capabilities while managing costs effectively.